Rob Kessels

862 total citations
24 papers, 177 citations indexed

About

Rob Kessels is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Psychiatry and Mental health. According to data from OpenAlex, Rob Kessels has authored 24 papers receiving a total of 177 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Psychiatry and Mental health. Recurrent topics in Rob Kessels's work include Sexual function and dysfunction studies (6 papers), Head and Neck Cancer Studies (5 papers) and Sexuality, Behavior, and Technology (5 papers). Rob Kessels is often cited by papers focused on Sexual function and dysfunction studies (6 papers), Head and Neck Cancer Studies (5 papers) and Sexuality, Behavior, and Technology (5 papers). Rob Kessels collaborates with scholars based in Netherlands, United States and United Kingdom. Rob Kessels's co-authors include Jos Bloemers, Adriaan Tuiten, Arash Navran, Jeroen Gerritsen, Kim van Rooij, P.G.M. van der Heijden, Corrie A.M. Marijnen, Tomas Janssen, Jan‐Jakob Sonke and Leonard R. Derogatis and has published in prestigious journals such as PLoS ONE, Annals of Oncology and BMC Medical Research Methodology.

In The Last Decade

Rob Kessels

24 papers receiving 172 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob Kessels Netherlands 10 43 36 32 30 22 24 177
Stephanie Gallant United Kingdom 9 5 0.1× 45 1.3× 35 1.1× 5 0.2× 12 0.5× 13 202
Ha Kyoung Kim South Korea 14 8 0.2× 25 0.7× 13 0.4× 17 0.6× 5 0.2× 37 563
John Wong Singapore 9 21 0.5× 59 1.6× 13 0.4× 6 0.2× 16 0.7× 17 264
Anne Gasnier France 8 16 0.4× 27 0.8× 53 1.7× 38 1.3× 23 1.0× 15 237
Federica Zito Marino Italy 9 68 1.6× 54 1.5× 49 1.5× 2 0.1× 16 0.7× 26 256
Huaying Chen China 8 5 0.1× 46 1.3× 32 1.0× 13 0.4× 12 0.5× 28 281
Wallace Jones United States 5 25 0.6× 30 0.8× 59 1.8× 7 0.3× 7 251
Veronica Mattioli Italy 11 6 0.1× 102 2.8× 57 1.8× 3 0.1× 17 0.8× 29 284
Eva Fung Hong Kong 7 30 0.7× 10 0.3× 21 0.7× 1 0.0× 16 0.7× 18 184

Countries citing papers authored by Rob Kessels

Since Specialization
Citations

This map shows the geographic impact of Rob Kessels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Kessels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Kessels more than expected).

Fields of papers citing papers by Rob Kessels

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Kessels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Kessels. The network helps show where Rob Kessels may publish in the future.

Co-authorship network of co-authors of Rob Kessels

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Kessels. A scholar is included among the top collaborators of Rob Kessels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Kessels. Rob Kessels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ham, Renske M.T. ten, Maartje W. Rohaan, Maarten Egeler, et al.. (2025). Health-related quality of life of patients with metastatic melanoma treated with tumor-infiltrating lymphocytes compared with ipilimumab in a randomized phase III trial. Annals of Oncology. 36(10). 1154–1165. 1 indexed citations
3.
Ham, Renske M.T. ten, Maartje W. Rohaan, Inge Jedema, et al.. (2024). Cost-effectiveness of treating advanced melanoma with tumor-infiltrating lymphocytes based on an international randomized phase 3 clinical trial. Journal for ImmunoTherapy of Cancer. 12(3). e008372–e008372. 9 indexed citations
4.
Al‐Mamgani, Abrahim, Rob Kessels, Arash Navran, et al.. (2023). Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study). Clinical and Translational Radiation Oncology. 43. 100676–100676. 3 indexed citations
5.
Navran, Arash, Abrahim Al‐Mamgani, Rob Kessels, et al.. (2023). Phase I feasibility study of Olaparib in combination with loco-regional radiotherapy in head and neck squamous cell carcinoma. Clinical and Translational Radiation Oncology. 44. 100698–100698. 2 indexed citations
6.
Kessels, Rob, Anne M. May, Miriam Koopman, & Kit C. B. Roes. (2023). The Trial within Cohorts (TwiCs) study design in oncology: experience and methodological reflections. BMC Medical Research Methodology. 23(1). 117–117. 8 indexed citations
7.
Verheij, Marcel, Arash Navran, Abrahim Al‐Mamgani, et al.. (2023). 888P Phase I study of olaparib combined with loco-regional radiotherapy in patients with head and neck squamous cell carcinoma. Annals of Oncology. 34. S569–S569. 1 indexed citations
9.
Zeng, Haiyan, Dirk K.M. De Ruysscher, Marianne A. Kuenen, et al.. (2023). Self-Reported Cognitive Function and Quality of Life in Patients With SCLC in the Hippocampal Avoidance Prophylactic Cranial Irradiation Versus Prophylactic Cranial Irradiation Randomized Phase 3 Trial (NCT01780675). JTO Clinical and Research Reports. 4(5). 100506–100506. 3 indexed citations
10.
Al‐Mamgani, Abrahim, Rob Kessels, Tomas Janssen, et al.. (2022). The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction. Radiotherapy and Oncology. 168. 16–22. 16 indexed citations
11.
Borgers, Jessica S.W., Elisabeth M. Terveer, Monique E. van Leerdam, et al.. (2022). Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase Ib/IIa trial. BMC Cancer. 22(1). 1366–1366. 18 indexed citations
12.
Boer, Jan Paul de, Menno R. Vriens, Rachel S. van Leeuwaarde, et al.. (2021). Retrospective Analyses of 18 FDG-PET/CT Thyroid Incidentaloma in Adults: Incidence, Treatment, and Outcome in a Tertiary Cancer Referral Center. Thyroid. 31(11). 1715–1722. 5 indexed citations
13.
Al‐Mamgani, Abrahim, Rob Kessels, Arash Navran, et al.. (2021). Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes. Radiotherapy and Oncology. 162. 170–177. 9 indexed citations
14.
Valdimarsdóttir, Heiðdís, et al.. (2021). Cancer-related Fatigue in Relation to Chronotype and Sleep Quality in (Non-)Hodgkin Lymphoma Survivors. Journal of Biological Rhythms. 36(1). 71–83. 10 indexed citations
15.
Al‐Mamgani, Abrahim, Rob Kessels, C. Verhoef, et al.. (2020). Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma. Radiotherapy and Oncology. 149. 181–188. 7 indexed citations
16.
Kessels, Rob, Jos Bloemers, Adriaan Tuiten, & P.G.M. van der Heijden. (2019). Multilevel analyses of on-demand medication data, with an application to the treatment of Female Sexual Interest/Arousal Disorder. PLoS ONE. 14(8). e0221063–e0221063. 3 indexed citations
17.
Tuiten, Adriaan, Kim van Rooij, Jos Bloemers, et al.. (2018). 167 Efficacy and Safety of On-Demand use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials. The Journal of Sexual Medicine. 15(Supplement_3). S199–S200. 3 indexed citations
18.
Tuiten, Adriaan, K.B.E. Böcker, Jack van Honk, et al.. (2018). Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: A double-blind, randomized, placebo-controlled cross-over trial. Women s Health. 14. 1744923498–1744923498. 12 indexed citations
19.
Tuiten, Adriaan, Kim van Rooij, Jos Bloemers, et al.. (2017). Efficacy and Safety of On-Demand Use of 2 Treatments Designed for Different Etiologies of Female Sexual Interest/Arousal Disorder: 3 Randomized Clinical Trials. The Journal of Sexual Medicine. 15(2). 201–216. 27 indexed citations
20.
Kessels, Rob, et al.. (2017). Methods for assessing and controlling placebo effects. Statistical Methods in Medical Research. 28(4). 1141–1156. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026